Skip to main content
Figure 2 | World Journal of Surgical Oncology

Figure 2

From: Metallopanstimulin as a marker for head and neck cancer

Figure 2

Serial MPS-H levels in HNSCC patients treated and without clinical disease (No Disease) and patients with unresectable disease or receiving palliative therapy with persistent clinical disease (Alive with Disease). Error bars denote 1 standard deviation and vary widely in the AWD group due to its small size and patient attrition over time from death.

Back to article page